Heart pump data study aims to sharpen shock monitoring

NCT ID NCT06308055

Recruiting now Knowledge-focused Sponsor: Abiomed Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study gathers detailed, real-time information from the Impella heart pump and standard hospital monitors in 125 people with cardiogenic shock. The goal is to better understand how the pump and the body's vital signs work together. No new treatment is being tested; instead, researchers are collecting data to improve future care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOGENIC SHOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiogenic shock Shock, Cardiogenic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOGENIC SHOCK

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

IRCCS Ospedale San Raffaele
NOT_YET_RECRUITING

Milan, MI, 20132, Italy

Contact

Contact
UKSH Campus Kiel
NOT_YET_RECRUITING

Kiel, Schleswig-Holstein, 24105, Germany

Contact
Uniklinik RWTH Aachen
ACTIVE_NOT_RECRUITING

Aachen, North Rhine-Westphalia, 52074, Germany
Universitätsspital Basel
RECRUITING

Basel, Switzerland

Contact

Contact